Skip to main content

Table 1 Baseline characteristics of study patients (n = 36)

From: Warfarin and fibrinolysis - a challenging combination: an observational cohort study

n (%, 95% CI)
Age (years)* 70 (62-78)
Sex; men 28 (78%, 62-89%)
Previous medical history  
   ischaemic heart disease 21 (58%, 42-73%)
   hypertension 24 (67%, 50-80%)
   diabetes 11 (31%, 18-47%)
   myocardial infarction 17 (47%, 32-63%)
   thrombolysis 9 (25%, 14-41%)
   PCI or CABG 5 (14%, 6-29%)
   use of aspirin 2 (6%, 1-19%)
Signs before fibrinolysis  
   cardiac arrest 10 (28%, 16-44%)
   pulmonary oedema 1 (3%, 0-15%)
   cardiogenic shock 5 (14%, 6-29%)
Warfarin  
   prior use known before fibrinolysis 34 (94%, 81-99%)
   indication  
atrial fibrillation 20 (55.5%, 40-70%)
cerebrovascular disease 6 (17%, 7-32%)
pulmonary embolism 1 (3%, 0-15%)
deep vein thrombosis 2 (5.5%, 1-19%)
heart valve disease 3 (8%, 2-23%)
cardiomyopathy 4 (11%, 4-26%)
  1. * = median (IQR). PCI = Percutaneous Coronary Intervention, CABG = Coronary Artery Bypass Graft Surgery.
\